CapAI Plc, a prominent member of the FTSE 250, concluded its Annual General Meeting (AGM) on a high note, with all proposed resolutions passed with fervent support. The resolutions included the acknowledgment and adoption of the company’s annual accounts for the financial year that ended in September 2024, the approval of the executives’ remuneration report and policy, the reapportionment of the main company directors, and the appointment of a new company auditor. The meeting took place at the luxurious offices of Peterhouse Capital in London’s financial heartland.
Spire Healthcare Group has released its Block Listing Interim Review, revealing no changes in its security allocations for the six-month period from Sept 2024 to March 2025. The healthcare giant – known for its focus on high calibre healthcare provision – maintains a consistent approach, keeping its stakeholders informed through routine updates and market insights.
The latest Interim Review paints a picture of stability within the Group, with no change in the number of securities issued or allotted under the scheme during the reporting period. The number of unallotted securities under the scheme from the previous return was 6,911,646. Given that no increase in the block scheme has been applied for and the lack of securities issued during the period, the balance of unallotted securities remains undisturbed from its previous figure.